B of A Securities Initiates Coverage On Inovio Pharmaceuticals with Neutral Rating, Announces Price Target of $13
B of A Securities Initiates Coverage On Inovio Pharmaceuticals with Neutral Rating, Announces Price Target of $13
B of A Securities以中性評級啟動對Inovio製藥的覆蓋,宣佈目標價為13美元
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。